Eli Lilly Sues Par Pharma To Block Generic Effient
Eli Lilly and Co. Ltd. and other drugmakers sued Par Pharmaceutical Cos. Inc. on Friday in New Jersey federal court, alleging the company's proposed generic version of Effient, used to manage...To view the full article, register now.
Already a subscriber? Click here to view full article